Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Pharmaceuticals & Biotech
Create a narrative
Photocure
OB:PHO Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Photocure
Popular
Undervalued
Overvalued
Photocure
WA
Analyst Price Target
Consensus Narrative from 2 Analysts
Advancements In BLC Technology And Hexvix Launch Will Revolutionize Bladder Cancer Diagnosis
Key Takeaways Strategic initiatives in the U.S. and Europe, such as Blue Light Cystoscopy expansion and partnerships, are expected to drive significant revenue and market growth. Anticipated international launches and collaborations, particularly in China, are poised to enhance cash flow and profit margins through increased market penetration.
View narrative
NOK 84.50
FV
39.1% undervalued
intrinsic discount
12.15%
Revenue growth p.a.
Set as Fair Value
1
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
PHO
Photocure
Your Fair Value
NOK
Current Price
NOK 51.50
26.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-79m
959m
2015
2018
2021
2024
2025
2027
2030
Revenue NOK 959.4m
Earnings NOK 25.8m
Advanced
Set as Fair Value